| Alivus Life Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543322 |
NSE Symbol : ALIVUS |
P/E(TTM) : 26.52 |
|
ISIN Demat : INE03Q201024 |
Div & Yield% : 0.37 |
EPS(TTM) : 50.64 |
|
Book Value(₹) : 271.41 |
Market Cap(₹Cr) : 16,490.05 |
Face Value(₹) : 2.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,551.83 | 2,386.88 | 2,283.21 | 2,161.22 | 2,123.21 |
| Other Income | 60.41 | 34.57 | 12.04 | 28.96 | 14.70 |
| Stock Adjustments | -3.56 | -27.35 | 56.57 | 84.44 | -41.32 |
| Total Income | 2,608.68 | 2,394.10 | 2,351.82 | 2,274.62 | 2,096.59 |
| EXPENDITURE : | |||||
| Raw Materials | 1,024.27 | 1,010.09 | 1,025.21 | 1,068.56 | 977.96 |
| Power and Fuel Cost | 113.88 | 117.24 | 112.46 | 115.60 | 100.92 |
| Other Manufacturing Expenses | 212.31 | 177.41 | 163.64 | 137.17 | 124.04 |
| Selling and Administration Expenses | 88.46 | 83.58 | 64.12 | 65.47 | 48.19 |
| Miscellaneous Expenses | 65.26 | 36.93 | 41.97 | 36.39 | 46.01 |
| Employee Benefit Expenses | 272.47 | 251.70 | 258.16 | 180.18 | 168.72 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 832.04 | 717.15 | 686.29 | 671.25 | 630.76 |
| Interest | 5.37 | 2.41 | 1.55 | 0.55 | 27.96 |
| Gross Profit | 826.67 | 714.74 | 684.74 | 670.70 | 602.80 |
| Depreciation | 75.36 | 60.61 | 53.45 | 42.09 | 37.88 |
| Profit Before Tax | 751.31 | 654.13 | 631.29 | 628.61 | 564.92 |
| Current Tax | 183.89 | 162.44 | 152.21 | 150.61 | 137.63 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.93 | 6.06 | 8.19 | 11.04 | 8.57 |
| Reported Net Profit | 564.48 | 485.63 | 470.89 | 466.96 | 418.72 |
| Extraordinary Items | 14.81 | 7.29 | -0.53 | -0.41 | -0.55 |
| Adjusted Net Profit | 549.67 | 478.34 | 471.42 | 467.37 | 419.27 |
| Adjustment below Net Profit | 1.22 | -0.25 | -5.46 | -0.29 | -19.50 |
| Profit/Loss Balance carried down | 1,777.18 | 1,291.80 | 1,102.06 | 1,021.35 | 750.79 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 61.34 | 0.00 | 275.69 | 385.96 | 128.65 |
| P & L Balance carried down | 2,281.55 | 1,777.18 | 1,291.80 | 1,102.06 | 1,021.35 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 250.00 | 250.00 | 1,125.00 | 2,100.00 | 1,050.00 |
| Dividend Per Share(Rs) | 5.00 | 5.00 | 22.50 | 42.00 | 21.00 |
| Earnings Per Share-Unit Curr | 45.99 | 39.63 | 38.43 | 38.11 | 34.17 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 271.49 | 229.92 | 190.35 | 174.51 | 167.66 |
| Book Value(Adj)-Unit Curr | 271.49 | 229.92 | 190.35 | 174.51 | 167.66 |
